0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML Injection [Comirnaty 2025-2026]
RxNorm concept 2722614, branded drug (sbd). Prescribable name: COMIRNATY 2025-2026 vaccine, 0.3 ML Injection, 5y to < 12y.
- RxCUI
- 2722614
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2722614 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.3 ML Comirnaty 2025-2026 0.0333 MG/ML Injection; Comirnaty 2025-2026 vaccine, 0.3 ML Injection, 5y to < 12y
Related concepts
- SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML (SCDC, consists of)
- SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML [Comirnaty 2025-2026] (SBDC, consists of)
- Injection (DF, has dose form)
- Comirnaty 2025-2026 (BN, has ingredient)
- 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2722614 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2722614 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2722614. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.